top of page
Partnerships and Outlicensing
Meros advanced formulation technology can generate unique, targeted therapies, creating competitive advantage via product line extensions, adding value to older drugs and improving new compounds that show marginal performance on their own.
The Meros technology is available for collaborative development and outlicensing.
Contact Meros today to discuss how smart formulations can improve the performance of your therapeutic compounds.
Meros technology is covered by the following patents:
Country | Patent No. | Patent No. |
|---|---|---|
United States | 8,309,515 | 9,139,553 |
Canada | 2,646,425 | 2,857,023 |
United Kingdom | 1994081UK
| 2730604UK |
France | 1994081FR
| 2730604FR |
Switzerland | 1994081CH
| 2730604CH |
Germany | 602007036834
| 602007056634.7 |
Japan | 5933889 |
Novel Poly(ethylene oxide)-Block-Poly(ester)
Block Copolymers
Collaboration and outlicensing opportunities joanna@merospolymers.com
bottom of page